PTAC Postdoc-to-Faculty Transition Award
Supports postdocs transitioning to faculty roles to develop innovative gene and protein therapies for restoring or repairing CFTR function in cystic fibrosis.
Funder: Cystic Fibrosis Foundation
Due Dates (Anticipated): December 2026 | May 2027
Funding Amounts: Up to 3 years of postdoc support ($81,000–$86,000/year); 2 years of faculty phase support ($110,000/year); max total duration 5 years; indirect costs not allowed.
Summary: Supports postdoctoral researchers transitioning to faculty roles to advance research on therapies restoring or repairing CFTR function in cystic fibrosis.
Key Information: All deadlines are projected; confirm with the program page for updates.
Description
The PTAC Postdoc-to-Faculty Transition Award, part of the Cystic Fibrosis Foundation's Path to a Cure initiative, is designed to support postdoctoral researchers as they move toward independent faculty positions while conducting innovative research focused on restoring CFTR protein function or repairing/replacing the defective CFTR gene in individuals with cystic fibrosis (CF). The program emphasizes foundational concepts, novel strategies, and new technologies that can inform or translate into therapies for all people with CF, particularly those not currently served by existing small-molecule modulators. Supported research areas include gene insertion technologies, delivery of nucleic acid-based therapies, tools to assess immune responses to genetic therapies, and in vitro assays to evaluate efficacy and safety of novel interventions.
